Upon approval for listing on the Nagoya Exchange’s Main Market, we will apply for simultaneous listing on the Tokyo Stock Exchange’s Standard Market. The listing date is September 17, 2026, with the aim of improving liquidity and expanding the investor base.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6029","jir_company_name":"Atra Group Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-09-10","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/6029-20260910-01.pdf","jir_short_summary":"Upon approval for listing on the Nagoya Exchange's Main Market, we will apply for simultaneous listing on the Tokyo Stock Exchange's Standard Market. The listing date is September 17, 2026, with the aim of improving liquidity and expanding the investor base.","jir_summary":"### Summary of the News\nThis is a notice regarding listing approval on the Nagoya Stock Exchange\u2019s Main Market. The company, whose core business is the acupuncture and manual therapy clinic management support platform 'A-COMS,' will commence dual listing on the Tokyo Stock Exchange's Standard Market and the Nagoya Exchange. The goals are to expand the investor base and recognition, improve stock liquidity, and enhance dialogue with shareholders.\n\n### Upcoming Schedule and Impact\nThe listing is scheduled for September 17, 2026. Thereafter, the company's shares will be tradable on both markets. The details of the Nagoya market will be referenced by the company, and through IR activities the company will continue to disclose information and engage in dialogue to enhance corporate value.","jir_financial_highlights":"Unknown: Unknown (Unknown)","jir_category":"","jir_hashtags":"#AtraGroup, #ListingApproval, #MarketExpansion","jir_key_figures":"Listing date: 2026-09-17\nDual listing: Nagoya Stock Exchange Main Market and Tokyo Stock Exchange Standard Market\nTarget business: Acupuncture and manual therapy clinic management support platform 'A-COMS'","jir_meta_title":"\u3010Atra Group\u3011Nagoya Stock Exchange Listing Approval Notice\uff5cSeptember 10, 2026","jir_meta_description":"Announcing listing approval on the Nagoya Exchange\u2019s Main Market and dual listing on two markets. Explains growth opportunities for the A-COMS-core business and policy for investor information disclosure.","jir_og_title":"Nagoya Stock Exchange Listing Approval Notice\uff5cSeptember 10, 2026","jir_og_description":"Explains growth strategy for the A-COMS-core business and investor opportunities associated with listing on Nagoya and Tokyo markets.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":61235,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"general_ir","footnotes":""},"sector":[],"importance":[],"class_list":["post-112369","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n